The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections
Open accessAbstract
Pseudomonas aeruginosa is a major health challenge that causes recalcitrant multidrug-resistant infections, especially in immunocompromised and hospitalized patients. P. aeruginosa is an important cause of nosocomial and ventilator-associated pneumonia characterized by high prevalence and fatality rates. P. aeruginosa also causes chronic lung infections in individuals with cystic fibrosis. Multidrug- and totally drug-resistant strains of P. aeruginosa are increasing threats that contribute to high mortality in these patients. The pathogenesis of many P. aeruginosa infections depends on its ability to form biofilms, structured bacterial communities that can coat mucosal surfaces or invasive devices. These biofilms make conditions more favorable for bacterial persistence, as embedded bacteria are inherently more difficult to eradicate than planktonic bacteria. The molecular mechanisms that underlie P. aeruginosa biofilm pathogenesis and the host response to P. aeruginosa biofilms remain to be fully defined. However, it is known that biofilms offer protection from the host immune response and are also extremely recalcitrant to antimicrobial therapy. Therefore, development of novel therapeutic strategies specifically aimed at biofilms is urgently needed. Here, we review the host response, key clinical implications of P. aeruginosa biofilms, and novel therapeutic approaches to treat biofilms relevant to lung infections. Greater understanding of P. aeruginosa biofilms will elucidate novel avenues to improve outcomes for P. aeruginosa pulmonary infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mucoid conversion and increased alginate production alter the matrix and strengthen the chronic state of infection [3,4].”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [3]
In the citing paper
“In patients with cystic fibrosis (CF), Pseudomonas aeruginosa (P. aeruginosa) establishes chronic airway infections that are dominated by biofilm growth.”
From Understanding Pseudomonas aeruginosa Biofilms: Quorum Sensing, c-di-GMP Signaling, and Emerging Antibiofilm Approaches (2026) · cites this paper as [3]
In the citing paper
“In P. aeruginosa, the formation of biofilms is the most typical strategy to acquire adaptive antibiotic resistance.262,263”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [262]
In the citing paper
“Meanwhile, P. aeruginosa infection can also cope with antibiotic treatment by forming persistent cells or persisters, thereby preventing the synthesis of antibiotic targets.223,262,263”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [262]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 3×
“Bacterial biofilms are a significant cause of human infections, particularly chronic infections (3).”
BackgroundFlemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Meijer, L., Nelson, D. J., Riazanski, V., Gabdoulkhakova, A. G., Hery-Arnaud, G., Le Berre, R., Loaëc, N., Oumata, N., Galons, H., Nowak, E., et al. (2016) · Journal of Innate Immunity · doi:10.1159/000444256 · Cited by 4,992
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396 · cited 1×
“QS directs the generation of essential biofilm components, namely eDNA and the biosurfactant glycolipid, rhamnolipid, and is therefore necessary for the development of mature biofilms (10, 15).”
BackgroundPersister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052 · cited 1×
“Then, upon cessation of the antibiotic therapy, they can resume replication and repopulate the biofilm (86).”
BackgroundQuorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Attenuation of Pseudomonas aeruginosa virulence by quorum sensing inhibitors
Hentzer, M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg366 · Cited by 1,422
The hierarchy quorum sensing network in Pseudomonas aeruginosa
Lee, J., & Zhang, L. (2015) · Protein & Cell · doi:10.1007/s13238-014-0100-x · Cited by 1,346
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients
Smith, E. E., Buckley, D. G., Wu, Z., Saenphimmachak, C., Hoffman, L. R., D’Argenio, D. A., Miller, S. I., Ramsey, B. W., Speert, D. P., Moskowitz, S. M., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602138103 · Cited by 1,319
Lebeaux, D., Ghigo, J.-M., & Beloin, C. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00013-14 · Cited by 1,318
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
Saiman, L., Marshall, B. C., Mayer-Hamblett, N., Burns, J. L., Quittner, A. L., Cibene, D. A., Coquillette, S., Fieberg, A. Y., Accurso, F. J., Campbell III, P. W., et al. (2003) · JAMA · doi:10.1001/jama.290.13.1749 · Cited by 958
Biofilm infections, their resilience to therapy and innovative treatment strategies
Römling, U., & Balsalobre, C. (2012) · Journal of Internal Medicine · doi:10.1111/joim.12004 · Cited by 865
Multidrug Tolerance of Biofilms and Persister Cells
Lewis, K. (2008) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-540-75418-3_6 · Cited by 804
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Self-citationPseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients
Bjarnsholt, T., Jensen, P. Ø., Fiandaca, M. J., Pedersen, J., Hansen, C. R., Andersen, C. B., Pressler, T., Givskov, M., & Høiby, N. (2009) · Pediatric Pulmonology · doi:10.1002/ppul.21011 · Cited by 795
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspective
Folkesson, A., Jelsbak, L., Yang, L., Johansen, H. K., Ciofu, O., Høiby, N., & Molin, S. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2907 · Cited by 715
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W. (2008) · Infection and Immunity · doi:10.1128/iai.00318-08 · Cited by 696
Mulcahy, L. R., Burns, J. L., Lory, S., & Lewis, K. (2010) · Journal of Bacteriology · doi:10.1128/jb.01651-09 · Cited by 631
Pseudomonas biofilm matrix composition and niche biology
Mann, E. E., & Wozniak, D. J. (2012) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00322.x · Cited by 606
Lin, Y., Xu, J., Hu, J., Wang, L., Ong, S. L., Leadbetter, J. R., & Zhang, L. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03351.x · Cited by 544
Leid, J. G., Willson, C. J., Shirtliff, M. E., Hassett, D. J., Parsek, M. R., & Jeffers, A. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7512 · Cited by 525
Pseudomonas aeruginosa Biofilms in Disease
Mulcahy, L. R., Isabella, V. M., & Lewis, K. (2014) · Microbial Ecology · doi:10.1007/s00248-013-0297-x · Cited by 518
Kollef, M. H. (2008) · JAMA · doi:10.1001/jama.300.7.805 · Cited by 479
Identity and effects of quorum-sensing inhibitors produced by Penicillium species
Rasmussen, T. B., Skindersoe, M. E., Bjarnsholt, T., Phipps, R. K., Christensen, K. B., Jensen, P. O., Andersen, J. B., Koch, B., Larsen, T. O., Hentzer, M., et al. (2005) · Microbiology · doi:10.1099/mic.0.27715-0 · Cited by 469
Tseng, B. S., Zhang, W., Harrison, J. J., Quach, T. P., Song, J. L., Penterman, J., Singh, P. K., Chopp, D. L., Packman, A. I., & Parsek, M. R. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12155 · Cited by 466
Ajoene, a Sulfur-Rich Molecule from Garlic, Inhibits Genes Controlled by Quorum Sensing
Jakobsen, T. H., van Gennip, M., Phipps, R. K., Shanmugham, M. S., Christensen, L. D., Alhede, M., Skindersoe, M. E., Rasmussen, T. B., Friedrich, K., Uthe, F., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05919-11 · Cited by 458
Wu, H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh223 · Cited by 446
Bjarnsholt, T., Jensen, P. Ø., Rasmussen, T. B., Christophersen, L., Calum, H., Hentzer, M., Hougen, H.-P., Rygaard, J., Moser, C., Eberl, L., et al. (2005) · Microbiology · doi:10.1099/mic.0.27955-0 · Cited by 440
Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis
Nixon, G. M., Armstrong, D. S., Carzino, R., Carlin, J. B., Olinsky, A., Robertson, C. F., & Grimwood, K. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.112897 · Cited by 432
Jensen, P. Ø., Bjarnsholt, T., Phipps, R., Rasmussen, T. B., Calum, H., Christoffersen, L., Moser, C., Williams, P., Pressler, T., Givskov, M., et al. (2007) · Microbiology · doi:10.1099/mic.0.2006/003863-0 · Cited by 404
Azithromycin Inhibits Quorum Sensing in Pseudomonas aeruginosa
Tateda, K., Comte, R., Péchère, J.-C., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1930-1933.2001 · Cited by 401
McAllister, F., Henry, A., Kreindler, J. L., Dubin, P. J., Ulrich, L., Steele, C., Finder, J. D., Pilewski, J. M., Carreno, B. M., Goldman, S. J., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.404 · Cited by 398
Effect of DNase and Antibiotics on Biofilm Characteristics
Tetz, G. V., Artemenko, N. K., & Tetz, V. V. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00471-08 · Cited by 396
Attributable Mortality of Ventilator-Associated Pneumonia: A Reappraisal Using Causal Analysis
Bekaert, M., Timsit, J.-F., Vansteelandt, S., Depuydt, P., Vésin, A., Garrouste-Orgeas, M., Decruyenaere, J., Clec'h, C., Azoulay, E., & Benoit, D. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201105-0867oc · Cited by 395
Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients.
Martin, D. W., Schurr, M. J., Mudd, M. H., Govan, J. R., Holloway, B. W., & Deretic, V (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8377 · Cited by 392
Cystic fibrosis lung environment and Pseudomonas aeruginosa infection
Bhagirath, A. Y., Li, Y., Somayajula, D., Dadashi, M., Badr, S., & Duan, K. (2016) · BMC Pulmonary Medicine · doi:10.1186/s12890-016-0339-5 · Cited by 378
An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal
Harmsen, M., Yang, L., Pamp, S. J., & Tolker-Nielsen, T. (2010) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2010.00690.x · Cited by 376
Mucoid Pseudomonas aeruginosa is a marker of poor survival in cystic fibrosis
Henry, R. L., Mellis, C. M., & Petrovic, L. (1992) · Pediatric Pulmonology · doi:10.1002/ppul.1950120306 · Cited by 371
Biofilm Matrix and Its Regulation in Pseudomonas aeruginosa
Wei, Q., & Ma, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141020983 · Cited by 369
Jesaitis, A. J., Franklin, M. J., Berglund, D., Sasaki, M., Lord, C. I., Bleazard, J. B., Duffy, J. E., Beyenal, H., & Lewandowski, Z. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.8.4329 · Cited by 368
&NA; (2009) · Survey of Anesthesiology · doi:10.1097/01.sa.0000349824.51609.a5 · Cited by 367
Tateda, K., Ishii, Y., Horikawa, M., Matsumoto, T., Miyairi, S., Pechere, J. C., Standiford, T. J., Ishiguro, M., & Yamaguchi, K. (2003) · Infection and Immunity · doi:10.1128/iai.71.10.5785-5793.2003 · Cited by 346
Recognition of Host Immune Activation by Pseudomonas aeruginosa
Wu, L., Estrada, O., Zaborina, O., Bains, M., Shen, L., Kohler, J. E., Patel, N., Musch, M. W., Chang, E. B., Fu, Y.-X., et al. (2005) · Science · doi:10.1126/science.1112422 · Cited by 331
de la Fuente-Núñez, C., Reffuveille, F., Mansour, S. C., Reckseidler-Zenteno, S. L., Hernández, D., Brackman, G., Coenye, T., & Hancock, R. E. W. (2015) · Chemistry & Biology · doi:10.1016/j.chembiol.2015.01.002 · Cited by 323
Quorum Quenching by an N -Acyl-Homoserine Lactone Acylase from Pseudomonas aeruginosa PAO1
Sio, C. F., Otten, L. G., Cool, R. H., Diggle, S. P., Braun, P. G., Bos, R., Daykin, M., Cámara, M., Williams, P., & Quax, W. J. (2006) · Infection and Immunity · doi:10.1128/iai.74.3.1673-1682.2006 · Cited by 322
Regulation of biofilm formation in P seudomonas and B urkholderia species
Fazli, M., Almblad, H., Rybtke, M. L., Givskov, M., Eberl, L., & Tolker‐Nielsen, T. (2014) · Environmental Microbiology · doi:10.1111/1462-2920.12448 · Cited by 306
Phenotypes of Non-Attached Pseudomonas aeruginosa Aggregates Resemble Surface Attached Biofilm
Alhede, M., Kragh, K. N., Qvortrup, K., Allesen-Holm, M., van Gennip, M., Christensen, L. D., Jensen, P. Ø., Nielsen, A. K., Parsek, M., Wozniak, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027943 · Cited by 306
Airway acidification initiates host defense abnormalities in cystic fibrosis mice
Shah, V. S., Meyerholz, D. K., Tang, X. X., Reznikov, L., Abou Alaiwa, M., Ernst, S. E., Karp, P. H., Wohlford-Lenane, C. L., Heilmann, K. P., Leidinger, M. R., et al. (2016) · Science · doi:10.1126/science.aad5589 · Cited by 291
Inactivation of a Pseudomonas aeruginosa quorum-sensing signal by human airway epithelia
Chun, C. K., Ozer, E. A., Welsh, M. J., Zabner, J., & Greenberg, E. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308750101 · Cited by 290
Tosi, M. F., Zakem, H., & Berger, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114699 · Cited by 289
Feltner, J. B., Wolter, D. J., Pope, C. E., Groleau, M.-C., Smalley, N. E., Greenberg, E. P., Mayer-Hamblett, N., Burns, J., Déziel, E., Hoffman, L. R., et al. (2016) · mBio · doi:10.1128/mbio.01513-16 · Cited by 265
Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils
Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3693-3701.2005 · Cited by 263
Bjarnsholt, T., Jensen, P. Ø., Jakobsen, T. H., Phipps, R., Nielsen, A. K., Rybtke, M. T., Tolker-Nielsen, T., Givskov, M., Høiby, N., Ciofu, O., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010115 · Cited by 261
Novel Pseudomonas aeruginosa Quorum-Sensing Inhibitors Identified in an Ultra-High-Throughput Screen
Müh, U., Schuster, M., Heim, R., Singh, A., Olson, E. R., & Greenberg, E. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00665-06 · Cited by 259
Pier, G. B., Coleman, F., Grout, M., Franklin, M., & Ohman, D. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1895-1901.2001 · Cited by 258
Mishra, M., Byrd, M. S., Sergeant, S., Azad, A. K., Parsek, M. R., McPhail, L., Schlesinger, L. S., & Wozniak, D. J. (2012) · Cellular Microbiology · doi:10.1111/j.1462-5822.2011.01704.x · Cited by 243
Alhede, M., Bjarnsholt, T., Jensen, P. O., Phipps, R. K., Moser, C., Christophersen, L., Christensen, L. D., van Gennip, M., Parsek, M., Hoiby, N., et al. (2009) · Microbiology · doi:10.1099/mic.0.031443-0 · Cited by 226
Young, R. L., Malcolm, K. C., Kret, J. E., Caceres, S. M., Poch, K. R., Nichols, D. P., Taylor-Cousar, J. L., Saavedra, M. T., Randell, S. H., Vasil, M. L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023637 · Cited by 226
Pseudomonas aeruginosa Biofilms
Alhede, M., Bjarnsholt, T., Givskov, M., & Alhede, M. (2014) · Advances in Applied Microbiology · doi:10.1016/b978-0-12-800262-9.00001-9 · Cited by 225
Antibiofilm Peptides: Potential as Broad-Spectrum Agents
Pletzer, D., & Hancock, R. E. W. (2016) · Journal of Bacteriology · doi:10.1128/jb.00017-16 · Cited by 220
Yang, L., Rybtke, M. T., Jakobsen, T. H., Hentzer, M., Bjarnsholt, T., Givskov, M., & Tolker-Nielsen, T. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01283-08 · Cited by 219
Jakobsen, T. H., Bragason, S. K., Phipps, R. K., Christensen, L. D., van Gennip, M., Alhede, M., Skindersoe, M., Larsen, T. O., Høiby, N., Bjarnsholt, T., et al. (2012) · Applied and Environmental Microbiology · doi:10.1128/aem.05992-11 · Cited by 213
Eugenol inhibits quorum sensing at sub-inhibitory concentrations
Zhou, L., Zheng, H., Tang, Y., Yu, W., & Gong, Q. (2013) · Biotechnology Letters · doi:10.1007/s10529-012-1126-x · Cited by 212
Gunn, J. S., Bakaletz, L. O., & Wozniak, D. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.707547 · Cited by 211
Pulmonary TH2 response in Pseudomonas aeruginosa–infected patients with cystic fibrosis
Hartl, D., Griese, M., Kappler, M., Zissel, G., Reinhardt, D., Rebhan, C., Schendel, D. J., & Krauss-Etschmann, S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2005.09.023 · Cited by 208
Sarabhai, S., Sharma, P., & Capalash, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053441 · Cited by 207
Ebbensgaard, A., Mordhorst, H., Overgaard, M. T., Nielsen, C. G., Aarestrup, F. M., & Hansen, E. B. (2015) · PLOS ONE · doi:10.1371/journal.pone.0144611 · Cited by 196
Tiringer, K., Treis, A., Fucik, P., Gona, M., Gruber, S., Renner, S., Dehlink, E., Nachbaur, E., Horak, F., Jaksch, P., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201206-1150oc · Cited by 187
Biotechnological applications of quorum quenching enzymes
Bzdrenga, J., Daudé, D., Rémy, B., Jacquet, P., Plener, L., Elias, M., & Chabrière, E. (2017) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2016.05.028 · Cited by 187
Kolpen, M., Hansen, C. R., Bjarnsholt, T., Moser, C., Christensen, L. D., van Gennip, M., Ciofu, O., Mandsberg, L., Kharazmi, A., Doring, G., et al. (2010) · Thorax · doi:10.1136/thx.2009.114512 · Cited by 184
Biofilms and host response – helpful or harmful
Moser, C. E., Pedersen, H. T., Lerche, C. J., Kolpen, M., Line, L., Thomsen, K., Høiby, N., & Jensen, P. Ø. (2017) · Apmis · doi:10.1111/apm.12674 · Cited by 182
Biofilm dispersion in Pseudomonas aeruginosa
Kim, S.-K., & Lee, J. (2016) · The Journal of Microbiology · doi:10.1007/s12275-016-5528-7 · Cited by 180
Olson, M. E., Harmon, B. G., & Kollef, M. H. (2002) · Chest · doi:10.1378/chest.121.3.863 · Cited by 177
Hoboth, C., Hoffmann, R., Eichner, A., Henke, C., Schmoldt, S., Imhof, A., Heesemann, J., & Hogardt, M. (2009) · The Journal of Infectious Diseases · doi:10.1086/599360 · Cited by 176
Human polymorphonuclear leukocyte response to Pseudomonas aeruginosa grown in biofilms
Jensen, E. T., Kharazmi, A., Lam, K., Costerton, J. W., & Høiby, N. (1990) · Infection and Immunity · doi:10.1128/iai.58.7.2383-2385.1990 · Cited by 173
Chua, S. L., Yam, J. K. H., Hao, P., Adav, S. S., Salido, M. M., Liu, Y., Givskov, M., Sze, S. K., Tolker-Nielsen, T., & Yang, L. (2016) · Nature Communications · doi:10.1038/ncomms10750 · Cited by 165
Watters, C., Fleming, D. F., Bishop, D. K., & Rumbaugh, K. P. (2016) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2016.05.007 · Cited by 159
Bijtenhoorn, P., Mayerhofer, H., Müller-Dieckmann, J., Utpatel, C., Schipper, C., Hornung, C., Szesny, M., Grond, S., Thürmer, A., Brzuszkiewicz, E., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026278 · Cited by 158
Tolker‐Nielsen, T. (2014) · Apmis · doi:10.1111/apm.12335 · Cited by 156
Pseudomonas biofilms: possibilities of their control
Masák, J., Čejková, A., Schreiberová, O., & Řezanka, T. (2014) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12344 · Cited by 146
Paraoxonase-2 deficiency enhancesPseudomonas aeruginosaquorum sensing in murine tracheal epithelia
Stoltz, D. A., Ozer, E. A., Ng, C. J., Yu, J. M., Reddy, S. T., Lusis, A. J., Bourquard, N., Parsek, M. R., Zabner, J., & Shih, D. M. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00370.2006 · Cited by 145
Smyth, A. R., Cifelli, P., Ortori, C. A., Righetti, K., Lewis, S., Erskine, P., Holland, E. D., Givskov, M., Williams, P. M., Cámara, M., et al. (2010) · Pediatric Pulmonology · doi:10.1002/ppul.21193 · Cited by 141
Azithromycin Blocks Neutrophil Recruitment in Pseudomonas Endobronchial Infection
Tsai, W. C., Rodriguez, M. L., Young, K. S., Deng, J. C., Thannickal, V. J., Tateda, K., Hershenson, M. B., & Standiford, T. J. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200402-200oc · Cited by 138
Pseudomonas aeruginosa Ventilator-associated Pneumonia. Predictive Factors of Treatment Failure
Planquette, B., Timsit, J., Misset, B., Schwebel, C., Azoulay, É., Adrie, C., Vesin, A., Jamali, S., Zahar, J., Allaouchiche, B., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201210-1897oc · Cited by 129
Skindersoe, M. E., Zeuthen, L., Brix, S., Fink, L. N., Lazenby, J., Whittall, C., Williams, P. M., Diggle, S. P., Froekiaer, H., Cooley, M. A., et al. (2009) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.2008.00533.x · Cited by 122
Inhaled Lactonase Reduces Pseudomonas aeruginosa Quorum Sensing and Mortality in Rat Pneumonia
Hraiech, S., Hiblot, J., Lafleur, J., Lépidi, H., Papazian, L., Rolain, J., Raoult, D., Elias, M. H., Silby, M. W., Bzdrenga, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107125 · Cited by 120
Bayer, A. S., Speert, D. P., Park, S., Tu, J., Witt, M. D., Nast, C. C., & Norman, D. C. (1991) · Infection and Immunity · doi:10.1128/iai.59.1.302-308.1991 · Cited by 107
Hultqvist, L. D., van Gennip, M., Rybtke, M., Wu, H. W., Chiang, W., Alhede, M., Høiby, N., Nielsen, T. E., Givskov, M., & Tolker‐Nielsen, T. (2013) · Infection and Immunity · doi:10.1128/iai.00332-13 · Cited by 102
Decraene, A., Willems‐Widyastuti, A., Kasran, A., Boeck, K. D., Bullens, D. M. A., & Dupont, L. (2010) · Respiratory Research · doi:10.1186/1465-9921-11-177 · Cited by 99
Vikström, E., Tafazoli, F., & Magnusson, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.11.057 · Cited by 95
Mahenthiralingam, E., & Speert, D. P. (1995) · Infection and Immunity · doi:10.1128/iai.63.11.4519-4523.1995 · Cited by 87
Bandyopadhaya, A., Tsurumi, A., Maura, D., Jeffrey, K. L., & Rahme, L. G. (2016) · Nature Microbiology · doi:10.1038/nmicrobiol.2016.174 · Cited by 86
Strempel, N., Neidig, A., Nusser, M., Geffers, R., Vieillard, J., Lesouhaitier, O., Brenner‐Weiß, G., & Overhage, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082240 · Cited by 83
Glucksam, Y., Sananes, R., Silberstein, N., Krief, P., Kravchenko, V. V., Meijler, M. M., & Zor, T. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300368 · Cited by 82
Kohler, T., Guanella, R., Carlet, J. M., & van Delden, C. (2010) · Thorax · doi:10.1136/thx.2009.133082 · Cited by 76
Tanaka, G., Shigeta, M., Komatsuzawa, H., Sugai, M., Suginaka, H., & Usui, T. (1999) · Chemotherapy · doi:10.1159/000007162 · Cited by 72
Blier, A.-S., Véron, W., Bazire, A., Gerault, E., Taupin, L., Vieillard, J., Vallée‐Rehel, K., Dufour, A., Derf, F. L., Orange, N., et al. (2011) · Microbiology · doi:10.1099/mic.0.046755-0 · Cited by 67
Increased Susceptibility to Pulmonary Pseudomonas Infection in Splunc1 Knockout Mice
Liu, Y., Di, M. E., Chu, H. W., Liu, X., Wang, L., Wenzel, S. E., & Di, Y. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202340 · Cited by 58
Crabbé, A., Ledesma, M. A., & Nickerson, C. A. (2014) · Pathogens and Disease · doi:10.1111/2049-632x.12180 · Cited by 57
Tam, M., Snipes, G. J., & Stevenson, M. M. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.4.3223 · Cited by 56
Huse, H., Kwon, T., Zlosnik, J. E. A., Speert, D. P., Marcotte, E. M., & Whiteley, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082621 · Cited by 53
Role of PON2 in innate immune response in an acute infection model
Devarajan, A., Bourquard, N., Grijalva, V. R., Gao, F., Ganapathy, E., Verma, J., & Reddy, S. T. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.07.003 · Cited by 42
Host environmental signals and effects on biofilm formation
Feraco, D., Blaha, M., Khan, S., Green, J. M., & Plotkin, B. J. (2016) · Microbial Pathogenesis · doi:10.1016/j.micpath.2016.08.015 · Cited by 41
Tan, R. M., Kuang, Z., Hao, Y., Lee, F., Lee, T. T., Lee, R. J., & Lau, G. W. (2015) · Infection and Immunity · doi:10.1128/iai.02874-14 · Cited by 38
Mittal, R., Sharma, S., Chhibber, S., & Harjai, K. (2006) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2005.11.002 · Cited by 37
Ciofu, O., Bagge, N., & Høiby, N. (2002) · Apmis · doi:10.1034/j.1600-0463.2002.1101207.x · Cited by 36
Enhanced Clearance of Pseudomonas aeruginosa by Peroxisome Proliferator-Activated Receptor Gamma
Bedi, B., Yuan, Z., Joo, M., Zughaier, S. M., Goldberg, J. B., Arbiser, J. L., Hart, C. M., & Sadikot, R. T. (2016) · Infection and Immunity · doi:10.1128/iai.00164-16 · Cited by 36
Self-citationJensen, P. Ø., Moser, C. E., Kobayashi, O., Hougen, H. P., Kharazmi, A., & Høiby, N. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02554.x · Cited by 35
Bedi, B., Maurice, N. M., Ciavatta, V. T., Lynn, K. S., Yuan, Z., Molina, S. A., Joo, M., Tyor, W. R., Goldberg, J. B., Koval, M. H., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700075r · Cited by 35
Self-citationYang, J., Lee, K., Park, S., Cho, Y., Lee, E., Park, J., Shin, O. S., Son, J. J., Yoon, S. S., & Yu, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00333 · Cited by 32
Dosunmu, E. F., Emeh, R. O., Dixit, S., Bakeer, M. K., Coats, M. T., Owen, D. R., Pillai, S., Singh, S. R., & Dennis, V. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176640 · Cited by 29
Griffin, P., Roddam, L. F., Belessis, Y., Strachan, R. E., Beggs, S. A., Jaffé, A., & Cooley, M. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042241 · Cited by 28
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance
Uruén, C., Chopo-Escuin, G., Tommassen, J., Mainar-Jaime, R. C., & Arenas, J. (2020) · Antibiotics · doi:10.3390/antibiotics10010003 · Cited by 769
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update
Reynolds, D., & Kollef, M. (2021) · Drugs · doi:10.1007/s40265-021-01635-6 · Cited by 721
Pseudomonas aeruginosa: An Audacious Pathogen with an Adaptable Arsenal of Virulence Factors
Jurado-Martín, I., Sainz-Mejías, M., & McClean, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063128 · Cited by 698
Antibiotics bioremediation: Perspectives on its ecotoxicity and resistance
Kumar, M., Jaiswal, S., Sodhi, K. K., Shree, P., Singh, D. K., Agrawal, P. K., & Shukla, P. (2019) · Environment International · doi:10.1016/j.envint.2018.12.065 · Cited by 558
Metadata
- Authors
- Maurice, N. M., Bedi, B., & Sadikot, R. T.
- Venue
- American Journal of Respiratory Cell and Molecular Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-04-01
- Volume
- 58
- Issue
- 4
- Pages
- 428-439
- ISSN
- 1044-1549 (ISSN-L)
- 1535-4989
- OpenAlex
- W2787181633
- Cited by
- 373
- References
- 115
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.